INTRODUCTION
Glycerol-stabilised cell extracts of Streptomyces clavuligerus contain an enzyme activity which synthesises ACV from the individual amino acids L-a-aminoadipic acid, t-cysteine and L-valine. Enzyme activity was optimum in reaction mixtures containing 1 mM ATP together with an ATP regenerating system. The ACV synthetase enzyme formed ACV analogs when provided with Lcarboxymethylcysteine in place of L-a-aminoadipic acid or when provided with L-alloisoleucine or L-a-aminobutyrate in place of L-valine. Multistep conversion of individual amino acids to penicillin and cephalosporin antibiotics was restricted as a result of the inhibitory effects of L-c~-aminoadipic acid and L-cysteine on isopenicillin N synthetase.
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Beta-lactam antibiotics are produced biosynthetically by a limited group of microorganisms, including both eukaryotic and prokaryotic species. In all species so far investigated, the biosynthesis of penicillin and cephalosporin compounds involves the tripeptide •-(L-a-aminoadipyl)-Lcysteinyl-D-valine (ACV) as an early intermediate. While the enzymatic reaction which converts ACV into the penicillin nucleus has been studied extensively [1] [2] [3] [4] , the reaction(s) giving rise to ACV have been much more resistant to analysis [5, 6] . Early studies on ACV biosynthesis concentrated on the analogy of the ACV structure with that of glutathione, and searched for similar biosynthetic routes involving two enzymes [7] . In these early studies, however, overall production of ACV was limited to a fraction of a percent of the added substrates. Recently, Banko et al. [8, 9] have shown that ACV synthesis in Cephalosporium acremonium involves the action of a single multifunctional enzyme and thus is much more analogous to the synthesis of peptide antibiotics such as gramicidin S than it is to glutathione. We have conducted similar studies using the beta-lactam producing organism Streptomyces clauuligerus and wish to report the development of a cell-free system capable of synthesising ACV and various structural analogs from the appropriate component amino acids.
MATERIALS AND METHODS

Materials
, bis-L-cysteinyl-D-valine (bis-CV) and bis-8-(L-a-aminoadipyl)-L-cysteine (bis-AC) were chemically synthesized as described previously [10, 11] . Monobromobimane (Thiolyte MB) was purchased from Calbiochem.
Bacterial strains and cultiuation
S. clauuligerus NRRL 3585 was stored as lyophilised spore preparations. For production of cell-free extracts, cultures were grown in trypticase soy broth containing 1% (w/v) soluble starch as described previously [4] . 
Preparation of cell-free extracts
A CV synthetase assay system
ACV synthetase activity was monitored in reaction mixtures containing: 1.0 mM ATP; 3.0 mM MgCI2; 2.0 mM dithiothreitol(DTT); 5.0 mM phosphoenol pyruvate(PEP); 0.64 units pyruvate kinase; 0.1 M MOPS/NaOH buffer, pH 7.5; 5.0 mM L-a-aminoadipic acid; 1.0 mM L-cysteine; 5.0 mM L-valine and 0.025 ml of desalted cell-free extract, all in a final volume of 0.1 ml. Assays were incubated at 25°C and terminated by the addition of 25 /~1 of 20% (w/v) trichloroacetic acid.
Small amounts (1 ml) of cell-free extract were desalted by gel centrifugation chromatography through Sephadex G-10 [11] . Larger amounts (10 ml) were desalted by gel filtration on a Sephadex G-25 column (2.5 × 35 cm) which was equilibrated and eluted with 0.1 M MOPS buffer, pH 7.5, containing 0.05 M KC1 and 20% (w/v) glycerol. Desalted cell-free extract was stored at-75°C with no detectable loss of activity for several months and contained about 20 mg protein/ml as determined by the dye binding method of Bradford [12] .
High -performance liquid chromatographic (HPLC) analysis of reaction mixtures
Reaction mixtures were analysed for ACV content by HPLC after pre-column derivatisation of thiol-containing compounds using a modification of the method of Newton et al. [13] .
Derivatisation. Precipitated protein was re- Samples were analysed using a 15-min linear gradient from 90% A:10% B to 55% A:45% B followed by a 15-min period of isocratic elution at 55% A:45% B. Flow rate was 1.5 ml/min and detection employed a 360-nm excitation filter and a 455-nm emission filter.
RESULTS AND DISCUSSION
Demonstration of ACV synthetase activity in Streptomyces clavuligerus
Cell-free extracts from S. clavuligerus contained ACV synthetase activity when prepared with glycerol-containing buffers. Incubation of these cell free extracts with L-a-aminoadipic acid, L-cysteine and L-valine, under the standard assay conditions described in Sect. 3, resulted in the formation of ACV. After derivatisation of thiolcontaining compounds, ACV could be resolved from other components of the reaction mixture by reversed phase HPLC ( 
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synthesis of ACV was determined to be 37.8 × 10 -6 units/mg protein, where 1 unit of enzyme synthesises 1 /~mole of ACV/min. The specific activity of ACV synthetase in cell-free extracts used in this study varied from 37.8 to 110.9 × 10 -6 units/mg protein when assayed under the optimized assay conditions described in Sect. 3. The highest of these values approached the specific activity observed by Banko et al. [9] for ACV synthetase activity in extracts from C. acremonium (130 × 10 -6 units/mg protein), but was still more than an order of magnitude lower than the specific activity of the other enzymes of the penicillin and cephalosporin biosynthetic pathway. Cell-free extracts from S. clavuligerus contain isopenicillin N synthetase activity with a specific activity of 1600 × 10 -6 units/mg protein [4] . Nonetheless, ACV synthetase activity could be monitored easily since the precolumn derivatisation procedure allowed detection and quantitation of ACV down to picomole levels. Other thiol-containing components of the reaction mixture were also apparent in the chromatogram including cysteine, retention time, 9.6 min and dithiothreitol, retention time, 20.4 min.
The assay system used to measure ACV synthetase activity in cell-free extracts from S. clavuligerus differed from that originally described by Banko et al., for the assay of extracts, or to simplify the reaction mixture without affecting activity. The original assay system contained cycloheximide, as a protein synthesis inhibitor. Cycloheximide was replaced with chloramphenicol in our prokaryotic system, but then was eliminated from the assay system when no difference in activity was observed in the presence or absence of chloramphenicol. Similarly, the original assay system indicated that reaction mixtures should be incubated on a rotary shaker, but no difference in activity was noted when reaction mixtures were incubated in a stationary water bath. Dithiothreitol concentration was also reduced from 5 mM to 2 mM because this did not affect enzyme activity, and allowed the amount of thiol-specific derivatising reagent to be reduced.
The assay system was also modified with respect to the energy generating components, to enhance ACV synthetase activity ( Table 1 ). Addition of The original reaction mixture of Banko et al. [9] contained l0 mM ATP+10 mM MgCI 2 and did not contain ADP, PEP or pyruvate kinase.
ADP to the assay system inhibited ACV synthetase activity which suggested that activity might be improved if an ATP regenerating system was used rather than ATP alone. Addition of phosphoenolpyruvate and pyruvate kinase to the assay system resulted in a modest increase in activity (125.7% relative to the original assay system). Greater improvement in activity was noted when the ATP concentration was reduced from the original 10 mM to 1 mM (191%) and a further increase resulted when the MgC12 concentration was adjusted to 3 mM (307.9%). Increasing MgC12 to 10 mM gave no further increase in activity.
ACV synthetase activity against various amino acid and peptide substrates
The substrate specificity of ACV synthetase from S. clavuligerus was tested by substituting equimolar amounts of a variety of amino acids or dipeptides in place of one or more amino acid constituents of the normal assay system ( Table 2) 
together with L-valine was a poor substrate combination for ACV synthetase since ACV formation was only 7.8% of that seen with the three individual amino acids. This corresponds to the findings of Banko et al. for the ACV synthetase from C. acremonium and supports the contention that ACV synthetase is a single multifunctional enzyme [9] .
Although L-lysine is a biosynthetic precursor of c~-aminoadipic acid in Streptomyces, no synthesis of ACV was seen when IAysine replaced L-c~-aminoadipate in the assay system. When L-carboxymethylcysteine (CMC) replaced L-a-aminoadipate, the CMC analog of ACV was formed. The identity of this and other ACV peptide analogs was confirmed by comparison with authentic standards. The area under the CMC-CV peak suggested that the amount of analog formed was 19.1% of the amount of ACV formed under identical conditions. When L-allo-isoleucine (alloI) and L-c~-aminobutyrate (aB) were provided to reaction mixtures in place of L-valine, the corresponding ACV analogs were formed in amounts representing 53.8% and 75.7%, respectively, of the amount of ACV formed from the natural amino acids. In contrast, neither D-valine nor ~,-isoleucine was able to support tripeptide formation when used in place of L-valine.
The efficiencies of formation of these various ACV analogs were quite different from those seen for the corresponding system from C. acremonium [9] . Kinetic characteristics of the two enzymes Table 2 Formation of ACV analogues by ACV synthetase
a t.-cysteinyI-D-valine eluted with a retention time which overlapped with that for ACV in the HPLC system used to analyse reaction mixtures.
were therefore compared by determining the K m of the S. clavuligerus enzyme for the three natural amino acids. Using the standard assay conditions, two of the amino acid components were held constant at the levels indicated in Sect. 3, while the third was varied. The concentration of L-aaminoadipic acid was varied from 0.5 mM to 2.5 mM, I_-cysteine was varied from 0.02 mM to 0.10 mM and L-valine was varied from 0.5 mM to 2.5 mM. The apparent K m values of the enzyme for the amino acids are: c~-aminoadipate 0.56 raM, cysteine 0.07 mM, and valine 1.14 mM. These values are all about 3 times higher than the corresponding values reported for C. acremonium but they show the same general pattern.
Conversion of free amino acids into penicillins and cephalosporins
The multistep conversion of L-a-aminoadipate, L-cysteine and L-valine into penicillins and cephalosporins was investigated by supplementing the ACV synthetase assay system with iron and ascorbate at final concentrations of 45 ~M and 2.8 mM, respectively, as are found in the IPNS assay system [4] , or with iron, ascorbate and c~-ketoglutarate at final concentrations of 45 /~M, 2.8 mM, and 1.0 mM as are found in the desacetoxycephalosporin C synthetase (DAOCS) assay system [14] . Under these conditions, only small amounts of antibiotic activity were produced (zone of inhibition = 9.5 mm), but the antibiotic formed under IPNS assay conditions was penicillinasesensitive while that formed under DAOCS assay conditions was penicillinase-resistant. Analysis of these reaction mixtures by HPLC showed that a large peak of ACV remained. The inability of these extracts to form large amounts of antibiotic must therefore be a result of the absence of the subsequent enzymes in the pathway, or the inhibition of the subsequent enzyme activities by components of the ACV synthetase assay system. To investigate these alternative possibilities, the desalted cell extract used as a source of ACV synthetase activity was assayed for IPNS activity under the standard assay conditions described previously [4] . Additional assays were prepared and supplemented with various components of the ACV synthetase assay system to determine whether 217 any of the components were inhibitory to IPNS activity ( Table 3 ). The desahed cell extract had good IPNS activity, but both L-a-aminoadipate and L-cysteine, at concentrations found in the ACV synthetase assay system, caused a marked inhibition of IPNS activity. High levels of enzymatic conversion of individual amino acids into penicillins and cephalosporins will apparently require a two-stage process to avoid the inhibitory effect of the free amino acids on IPNS activity.
